Acuvi Q3 2022: First impression - Redeye

Redeye sees good progress in the third quarter, although we had hoped for even a little bit more. Organic growth of 15% is encouraging, but double-digit growth is expected from Acuvi. Adjusted gross margins were 31%, somewhat lower than H1, probably due to sales mix. Overall, the market climate and Acuvi’s outlook remains positive with a number of significant orders announced lately. We have probably been a bit too optimistic about the near-term prospects and will most likely need to lower our forecasts.

Länk till analysen i sin helhet: https://www.redeye.se/research/862470/acuvi-q3-2022-first-impression?utm_source=finwire&utm_medium=RSS